| Aspira Womens Health is engaged in the discovery, development and commercialization of diagnostic and bio-analytical solutions. Co.'s products and related services include: OVA1, a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at high risk of having a malignant ovarian tumor prior to planned surgery; Overa, a biomarker panel; OVA1PLUS, a service offering combining its OVA1 and Overa products; and ASPiRA GenetiX, a genetic test for women's health diseases, which is focused on detecting hereditary breast and ovarian cancer syndrome; and Carrier screening, genetic screening for carriers of disease. We show 6 historical shares outstanding datapoints in our AWH shares outstanding history coverage, used to compute AWH market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AWH market cap history over the course of time is important for investors
interested in comparing AWH's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AWH versus a peer is one thing; comparing
AWH market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AWH can fluctuate over the course of history.
With this page we aim to empower investors researching AWH by allowing them to research the AWH market cap history.